{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5ef0ad954320b108b12f7e8d/6ad73dd7d068f31796fa4577?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"What are the key clinical considerations for the use of ECP in steroid-refractory GvHD?​​","description":"<p>The GvHD Hub spoke with Daniel Wolff, University Hospital Regensburg, Regensburg, DE. We asked, What are the key clinical considerations for the use of ECP in SR-GvHD?​​ In this interview, Wolff discusses factors guiding the use of extracorporeal photopheresis in steroid-refractory graft-versus-host disease. Treatment decisions should account for patient- and disease-related factors, including cytopenias, risk of infection or malignant relapse, and organ involvement, alongside practical considerations, such as venous access, treatment frequency, and the commitment required for long-term therapy. Intended for healthcare professionals. This educational resource is independently supported by Therakos. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence.</p>","author_name":"Scientific Education Support"}